Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ugolini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|October 27, 2018
Dead or alive: how the immune system detects microbial viabilityMatteo Ugolini, Leif E Sander
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearanceVincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Nature Immunology|June 28, 2016
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defenseJohan Garaude, Rebeca Acín-Pérez, Sarai Martínez-Cano, et al.
Cancer Research|March 8, 2012
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirusIulia Diaconu, Vincenzo Cerullo, Mari L M Hirvinen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal DementiaGianmarco Guarnier, Janis Reinelt, Eóin N Molloy, et al.
EMBO Reports|September 9, 2025
Streptococcus pyogenes EVs induce the alternative inflammasome via caspase-4/-5 in human monocytesKathrin Krause, Sandra Franch Arroyo, Matteo Ugolini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2010
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSFAnniina Koski, Lotta Kangasniemi, Sophie Escutenaire, et al.
Cancer Research|May 21, 2010
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patientsVincenzo Cerullo, Sari Pesonen, Iulia Diaconu, et al.
Nature Immunology|March 21, 2018
Recognition of microbial viability via TLR8 drives T<sub>FH</sub> cell differentiation and vaccine responsesMatteo Ugolini, Jenny Gerhard, Sanne Burkert, et al.
Science (New York, N.Y.)|November 25, 2010
Plasticity of animal genome architecture unmasked by rapid evolution of a pelagic tunicateFrance Denoeud, Simon Henriet, Sutada Mungpakdee, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|October 27, 2018
Dead or alive: how the immune system detects microbial viabilityMatteo Ugolini, Leif E Sander
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearanceVincenzo Cerullo, Iulia Diaconu, Valentina Romano, et al.
Nature Immunology|June 28, 2016
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defenseJohan Garaude, Rebeca Acín-Pérez, Sarai Martínez-Cano, et al.
Cancer Research|March 8, 2012
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirusIulia Diaconu, Vincenzo Cerullo, Mari L M Hirvinen, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Cascaded Multimodal Deep Learning in the Differential Diagnosis, Progression Prediction, and Staging of Alzheimer's and Frontotemporal DementiaGianmarco Guarnier, Janis Reinelt, Eóin N Molloy, et al.
EMBO Reports|September 9, 2025
Streptococcus pyogenes EVs induce the alternative inflammasome via caspase-4/-5 in human monocytesKathrin Krause, Sandra Franch Arroyo, Matteo Ugolini, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 29, 2010
Treatment of cancer patients with a serotype 5/3 chimeric oncolytic adenovirus expressing GMCSFAnniina Koski, Lotta Kangasniemi, Sophie Escutenaire, et al.
Cancer Research|May 21, 2010
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patientsVincenzo Cerullo, Sari Pesonen, Iulia Diaconu, et al.
Nature Immunology|March 21, 2018
Recognition of microbial viability via TLR8 drives T<sub>FH</sub> cell differentiation and vaccine responsesMatteo Ugolini, Jenny Gerhard, Sanne Burkert, et al.
Science (New York, N.Y.)|November 25, 2010
Plasticity of animal genome architecture unmasked by rapid evolution of a pelagic tunicateFrance Denoeud, Simon Henriet, Sutada Mungpakdee, et al.
Pageof 1